BGI-Shenzhen receives U.S. approval for Complete Genomics buy
Chinese genomics sequencing company BGI-Shenzhen has won U.S. antitrust clearance for its planned takeover of Nasdaq-listed rival Complete Genomics, according to a statement lodged with the U.S. Securities and Exchange Commission.Washington...To view the full article, register now.
Already a subscriber? Click here to view full article